title: White matter damage following systemic injection of the mitochondrial inhibitor 3-nitropropionic acid in rat.
abstract: Oxidative stress has been implicated as a pathogenic mediator of neuronal perikarya cell death. Axons and oligodendrocytes, components of white matter, could also be vulnerable to oxidative damage. An experimental model of oxidative stress was induced by systemic injection of 3-nitropropionic acid (3-NPA). Animals received an i.p. injection of 10, 15, 20 or 30 mg/kg 3-NPA or vehicle and were killed 24 h later. 3-NPA produced a concentration-dependent increase in axonal pathology within the striatum reflected by the amount of beta-APP and SNAP-25 accumulation. Axonal damage was anatomically coincident with the neuronal lesion. There was no neuronal or axonal damage in the subcortical white matter or cerebral cortex in any of the animals treated with 3-NPA. Manganese superoxide dismutase (Mn-SOD) immunoreactivity was present in the vehicle and all 3-NPA treated groups. The amount of Mn-SOD cellular staining was concentration-dependently increased within the striatum supporting a role for oxidative stress in the mechanism of 3-NPA neurotoxicity. Oligodendrocyte-like cells within the subcortical white matter were immunopositive for calpain-mediated spectrin breakdown products and increased in a concentration-dependent manner. Therefore in this experimental model, mitochondrial inhibition may lead to the initiation of oxidative stress and calpain activation, which could mediate cytoskeletal breakdown in axons and oligodendrocytes suggesting an interaction between at least two pathogenic mechanisms.
authors.affiliation: Wellcome Surgical Institute, University of Glasgow, Garscube Estate, Bearsden Road, G61 1QH, Glasgow, UK. emc27m@udcf.ac.uk
authors.forename: E
authors.initials: E
authors.lastname: McCracken
authors.forename: D
authors.initials: D
authors.lastname: Dewar
authors.forename: A J
authors.initials: AJ
authors.lastname: Hunter
mesh_terms: D016564:Amyloid beta-Protein Precursor / Q000378:metabolism; D000818:Animals; D001369:Axons / Q000378:metabolism; D001927:Brain Diseases / Q000139:chemically induced* / Q000473:pathology; D002154:Calpain / Q000378:metabolism; D003599:Cytoskeleton / Q000187:drug effects / Q000378:metabolism; D005609:Free Radicals / Q000378:metabolism; D007150:Immunohistochemistry; D008297:Male; D008928:Mitochondria / Q000187:drug effects*; D009457:Neuroglia / Q000187:drug effects / Q000502:physiology; D009498:Neurotoxins / Q000008:administration & dosage / Q000633:toxicity*; D009574:Nitro Compounds; D018384:Oxidative Stress / Q000187:drug effects*; D011422:Propionates / Q000008:administration & dosage / Q000633:toxicity*; D051381:Rats; D017207:Rats, Sprague-Dawley; D013482:Superoxide Dismutase / Q000378:metabolism
chemical_list: D016564:Amyloid beta-Protein Precursor; D005609:Free Radicals; D009498:Neurotoxins; D009574:Nitro Compounds; D011422:Propionates; D013482:Superoxide Dismutase; D002154:Calpain; C015392:3-nitropropionic acid